Amyloidosis NFZ — 43 facilities in 38 cities

Amyloidosis is a condition in which abnormal proteins (amyloid) deposit in organs, impairing their function. It can affect the heart, kidneys, liver, and nervous system. The NFZ covers diagnostics including biopsy and imaging, chemotherapy, daratumumab treatment, and stem cell transplantation in selected cases. Management requires multidisciplinary care across several specialties.